Dr Anita Barzegar Fallah

2023

Journal - Research Article

Barzegar-Fallah, A., Alimoradi, H., Dunlop, J. L., Torbati, E., & Baird, S. K. (2023). Serotonin type-3 receptor antagonists selectively kill melanoma cells through classical apoptosis, microtubule depolymerisation, ERK activation, and NF-κB downregulation. Cell Biology & Toxicology, 39, 1119-1135. doi: 10.1007/s10565-021-09667-0

2022

Journal - Research Article

Gandhi, K., Barzegar-Fallah, A., Banstola, A., Rizwan, S. B., & Reynolds, J. N. J. (2022). Ultrasound-mediated blood-brain barrier disruption for drug delivery: A systematic review of protocols, efficacy, and safety outcomes from preclinical and clinical studies. Pharmaceutics, 14, 833. doi: 10.3390/pharmaceutics14040833

Alimoradi, H., Thomas, A., Lyth, D. D. B., Barzegar-Fallah, A., Matikonda, S. S., Gamble, A. B., & Giles, G. I. (2022). SMA-BmobaSNO: An intelligent photoresponsive nitric oxide releasing polymer for drug nanoencapsulation and targeted delivery. Nanotechnology, 33, 195101. doi: 10.1088/1361-6528/ac4eb0

Journal - Research Other

Barzegar-Fallah, A., Gandhi, K., Rizwan, S. B., Slatter, T. L., & Reynolds, J. N. J. (2022). Harnessing ultrasound for targeting drug delivery to the brain and breaching the blood–brain tumour barrier. Pharmaceutics, 14(10), 2231. doi: 10.3390/pharmaceutics14102231

2021

Chapter in Book - Research

Barzegar-Fallah, A., Houlton, J., Barwick, D., Shavandi, A., Ali, M. A., Clarkson, A. N., & Alimoradi, H. (2021). From barriers to bridges: Glycans in naonparenteral nanomedicines. In P. Kesharwani, S. Taurin & K. Greish (Eds.), Theory and applications of nonparenteral nanomedicines. (pp. 467-487). London, UK: Elsevier. doi: 10.1016/B978-0-12-820466-5.00019-3

2020

Journal - Research Article

Mohammad, Y., Barzegar Fallah, A., Reynolds, J. N. J., Boyd, B. J., & Rizwan, S. B. (2020). Steric stabilisers govern the colloidal and chemical stability but not in vitro cellular toxicity of linoleoylethanolamide cubosomes. Colloids & Surfaces B, 192, 111063. doi: 10.1016/j.colsurfb.2020.111063

2019

Journal - Research Article

Alimoradi, H., Barzegar-Fallah, A., Sammut, I. A., Griesh, K., & Giles, G. I. (2019). Encapsulation of tDodSNO generates a photoactivated nitric oxide releasing nanoparticle for localized control of vasodilation and vascular hyperpermeability. Free Radical Biology & Medicine, 130, 297-305. doi: 10.1016/j.freeradbiomed.2018.10.433

2018

Journal - Research Article

Alimoradi, H., Greish, K., Barzegar-Fallah, A., Alshaibani, L., & Pittalà, V. (2018). Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity. International Journal of Nanomedicine, 13, 7771-7787. doi: 10.2147/ijn.S187089

Journal - Research Other

Alimoradi, H., Barzegar-Fallah, A., Sammut, I. A., Griesh, K., & Giles, G. I. (2018). Data characterizing the biophysical and nitric oxide release properties of the tDodSNO: Styrene maleic anhydride nanoparticle SMA-tDodSNO [Data article]. Data in Brief, 21, 1771-1775. doi: 10.1016/j.dib.2018.10.149

Conference Contribution - Published proceedings: Abstract

Alimoradi, H., Barzegarfallah, A., & Giresh, K. F. (2018). SMA-tDodSNO improves the potency of doxorubicin in breast cancer evidence for the involvement of oxidative stress. Annals of Oncology, 29(Suppl. 9), (pp. ix24). doi: 10.1093/annonc/mdy430.005

Barzegar Fallah, A., Alimoradi, H., & Baird, S. K. (2018). 5HT3 receptor antagonists selectively kill melanoma cells. Annals of Oncology, 29(Suppl. 9), (pp. ix107). doi: 10.1093/annonc/mdy439.009

2017

Conference Contribution - Published proceedings: Abstract

Alimoradi, H., Greish, K., Sammut, I., Barzegar-Fallah, A., & Giles, G. I. (2017). Induction of localized vasodilation and hyperpermeability using a novel nitric oxide donor nanoparticle. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 85). Retrieved from http://www.asceptasm.com/

Yarragudi, S. B., Barzegar-Fallah, A., Prentice, R. N., & Rizwan, S. B. (2017). Olfactory targeted mucoadhesive microparticles for enhanced brain uptake of phenytoin. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 84). Retrieved from http://www.asceptasm.com/

2016

Journal - Research Article

Barzegar-Fallah, N., Baery, N., Soleymankhani, M., Malekmohammadi, N., Alimoradi, H., Parsa, A., & Barzegar-Fallah, A. (2016). Kelussia odoratissima Mozaff attenuates thromboembolic brain injury, possibly due to its Z-ligustilide content. Brain Injury, 30(7), 926-932. doi: 10.3109/02699052.2016.1144083

2015

Journal - Research Article

Barzegar-Fallah, A., Alimoradi, H., Razmi, A., Dehpour, A. R., Asgari, M., & Shafiei, M. (2015). Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy. European Journal of Pharmacology, 767, 152-159. doi: 10.1016/j.ejphar.2015.10.019

Barzegar-Fallah, A., Alimoradi, H., Asadi, F., Dehpour, A. R., Asgari, M., & Shafiei, M. (2015). Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Clinical & Experimental Pharmacology & Physiology, 42(4), 361-368. doi: 10.1111/1440-1681.12373